{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:16:45Z","timestamp":1770416205191,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"publisher","award":["ZR2012HM037"],"award-info":[{"award-number":["ZR2012HM037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Project of Colleges in Shandong Province","award":["J12LK56"],"award-info":[{"award-number":["J12LK56"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30971081"],"award-info":[{"award-number":["30971081"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31271243"],"award-info":[{"award-number":["31271243"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81070961"],"award-info":[{"award-number":["81070961"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.vaccine.2017.02.024","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T11:48:19Z","timestamp":1487677699000},"page":"1599-1607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Anti-tumour research of recombinant BCG using BZLF1 and hGM-CSF fusion genes"],"prefix":"10.1016","volume":"35","author":[{"given":"Qing-jie","family":"Xue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baohua","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.02.024_b0005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/jmv.2152","article-title":"Evidence of lytic infection of Epstein-Barr virus (EBV) in EBV-positive gastric carcinoma","volume":"66","author":"Hoshikawa","year":"2002","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2017.02.024_b0010","doi-asserted-by":"crossref","first-page":"23345","DOI":"10.1074\/jbc.M107420200","article-title":"Epstein-Barr virus BZLF1 gene is activated by transforming growth factor-beta through cooperativity of Smads and c-Jun\/c-fos proteins","volume":"277","author":"Liang","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2017.02.024_b0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1128\/JVI.77.1.199-207.2003","article-title":"ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus","volume":"77","author":"Kraus","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.02.024_b0020","first-page":"68","article-title":"GM-CSF-armed vaccinia virus induces an antitumor immune response","volume":"10","author":"Parviainen","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2017.02.024_b0025","first-page":"1558","article-title":"Induction of T-cell immunity against Epstein-Barr virus-associated tumors by means of adenovirally transduced dendritic cells","volume":"117","author":"Sun","year":"2004","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.vaccine.2017.02.024_b0030","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00262-009-0673-z","article-title":"Recombinant bacillus Calmette-Gu\u00e9rin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro","volume":"58","author":"Liu","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.vaccine.2017.02.024_b0035","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1007\/s11033-012-1502-6","article-title":"Effect of active immunization against a recombinant mouse granulocyte-macrophage colony-stimulating factor\/somatostatin fusion protein on the growth of mice","volume":"39","author":"Wu","year":"2012","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.vaccine.2017.02.024_b0040","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/JVI.01303-09","article-title":"Novel approach to the formulation of an Epstein-Barr virus antigen-based nasopharyngeal carcinoma vaccine","volume":"84","author":"Lutzky","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.02.024_b0045","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CVI.00193-10","article-title":"Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients","volume":"18","author":"Hoebe","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2017.02.024_b0050","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/157015910792246191","article-title":"Recent advances on the possible neuroprotective activities of epstein-barr virus oncogene BARF1 protein in chronic inflammatory disorders of central nervous system","volume":"8","author":"Wynne","year":"2010","journal-title":"Curr Neuropharmacol"},{"issue":"6326","key":"10.1016\/j.vaccine.2017.02.024_b0055","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/351456a0","article-title":"New use of BCG for recombinant vaccines","volume":"351","author":"Stover","year":"1991","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2017.02.024_b0060","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pjnns.2015.12.003","article-title":"Spinal tuberculosis with severe neurological symptoms as a complication of intravesical BCG therapy for carcinoma of the bladder","volume":"50","author":"Bialecki","year":"2016","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.vaccine.2017.02.024_b0065","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/jmv.23901","article-title":"Construction of a recombinant-BCG containing the LMP2A and BZLF1 genes and its significance in the Epstein-Barr virus positive gastric carcinoma","volume":"86","author":"Xue","year":"2014","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.02.024_b0070","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1048-891X.2004.014206.x","article-title":"The anti-tumor immune responses induced by a fusion protein of ovarian carcinoma anti -idiotypic antibody 6BllScFv and murine GM-CSF in BALB\/c mice","volume":"14","author":"Cui","year":"2004","journal-title":"Gynecol Cancer"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17302189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17302189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T19:07:08Z","timestamp":1568833628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17302189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0264410X17302189"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.024","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-tumour research of recombinant BCG using BZLF1 and hGM-CSF fusion genes","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}